Dr. Daniel S. Berman[email protected]Nuclear MedicineScreening for CAD in diabetics: Which patient? Which test?Screening for coronary artery disease (CAD) in any population is controversial. In this editorial opinion, Dr. Daniel Berman of Cedars-Sinai Medical Center points out what he believes are shortcomings in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study published this week in the Journal of the American Medical Association.April 16, 2009Page 1 of 1Top StoriesMedicolegalClass-action suit filed against insurer for breast imaging chargesThe lawsuit alleges Oscar Health Insurance required policyholders to pay deductibles and coinsurance for diagnostic breast imaging in violation of Texas law.Womens ImagingAI model predicts breast cancer risk in diverse populationCTUltralow-dose CT leads to less radiation in osteoporosis patientsAIClairity deploys AI for breast cancer risk predictionSponsor ContentRegister today for our June 17 webinar